Sex differences in the prevalence and determinants of HPV-related external genital lesions in young adults: a national cross-sectional survey in Brazil

Imagem de Miniatura
Arquivos
art_COMERLATO_Sex_differences_in_the_prevalence_and_determinants_of_2020.PDF.pdf (794.46 KB)
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
COMERLATO, Juliana
KOPS, Natalia Luiza
BESSEL, Marina
HORVATH, Jaqueline Driemeyer
FERNANDES, Bruna Vieira
SOUZA, Flavia Moreno Alves de
PEREIRA, Gerson Fernando Mendes
WENDLAND, Eliana Marcia
Citação
BMC INFECTIOUS DISEASES, v.20, n.1, article ID 683, 8p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background External genital lesions (EGL) are the most common sexually transmitted infections (STIs). We aimed to evaluate the prevalence, determinants and sex differences in EGL among young adults from Brazil. Methods Overall, 7694 participants (aged 16 to 25 years) underwent an interview, genital examination and sampling for HPV genotyping. Results The prevalence of EGL was 4.08% (234) and is more frequent in men (5.72%) than women (2.31%) (p < 0.001). Genital lesions were significantly associated with male sex, infection by high-risk and multiple HPV types, having more than two sexual partners in the last year, smoking status and the presence of other STI. While alcohol use was associated with a higher prevalence of EGL in women, same-sex sexual relationship increase the prevalence in men. In the EGL group, 67.79% (p = 0.032) were positive for HPV infection and the types HPV6 and HPV11 were the most prevalent ones. Conclusion The prevalence of EGL in young adults was consistently high, and most cases were associated with genital HPV infection and STIs. Although men have a higher prevalence, both sexes share most genital lesion determinants. The promotion of sexual education and vaccination especially focus in young men, who are usually outside the targets of primary health care programmes, can prevent EGL in Brazilian young adults.
Palavras-chave
Human papillomavirus, Genital warts, HPV, Epidemiology, Prevalence in young adults
URI
https://observatorio.fm.usp.br/handle/OPI/38323
Referências
  1. [Anonymous], PROT CLIN DIR TER AT
  2. [Anonymous], 2017, DOIS MED TRAT HPV SA
  3. Bellaminutti S, 2014, J MED VIROL, V86, P1920, DOI 10.1002/jmv.24041
  4. Bhatia N, 2013, J CUTAN MED SURG, V17, pS47, DOI 10.2310/7750.2013.13072
  5. Campbell CMP, 2016, VIROLOGY, V497, P314, DOI 10.1016/j.virol.2016.08.002
  6. da Silva RJC, 2017, BRAZ J INFECT DIS, V21, P376, DOI 10.1016/j.bjid.2017.03.004
  7. Chesson HW, 2014, SEX TRANSM DIS, V41, P660, DOI 10.1097/OLQ.0000000000000193
  8. Cremin S, 2012, HUM VACC IMMUNOTHER, V8, P916, DOI 10.4161/hv.20122
  9. Crosbie EJ, 2013, LANCET, V382, P889, DOI 10.1016/S0140-6736(13)60022-7
  10. Dahlstrom KR, 2018, PHARMACOECONOMICS, V36, P1355, DOI 10.1007/s40273-018-0691-9
  11. de Lima S, 2008, CAD SAUDE PUBLICA, V24, P1910, DOI 10.1590/S0102-311X2008000800019
  12. Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252
  13. Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055
  14. Garcia PJ, 2019, INT J STD AIDS, V30, P264, DOI 10.1177/0956462418796088
  15. Gianino MM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-470
  16. Guerra FM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009914
  17. Hasanzadeh M, 2019, J CELL BIOCHEM, V120, P12870, DOI 10.1002/jcb.28557
  18. Hernandez-Suarez G, 2013, INT J STD AIDS, V24, P567, DOI 10.1177/0956462412474538
  19. Ingles DJ, 2015, J INFECT DIS, V211, P1060, DOI 10.1093/infdis/jiu587
  20. Khopkar US, 2018, VIRAL IMMUNOL, V31, P346, DOI 10.1089/vim.2017.0157
  21. Kim HS, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e49
  22. Lazcano-Ponce E, 2018, SALUD PUBLICA MEXICO, V60, P633, DOI 10.21149/8461
  23. Leslie SW, 2020, STATPEARLS INTERNET
  24. Luo Zhao-Yun, 2015, Asian Pac J Cancer Prev, V16, P5675
  25. Min KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072142
  26. Mohammed H, 2018, SEX TRANSM INFECT, V94, P553, DOI 10.1136/sextrans-2017-053273
  27. Muhr LSA, 2015, VIROLOGY, V485, P283, DOI 10.1016/j.virol.2015.07.023
  28. Nilyanimit P, 2018, INTERVIROLOGY, V61, P223, DOI 10.1159/000497351
  29. Onyekwuluje JM, 2012, CLIN LAB, V58, P61
  30. ostensson E, 2015, PLOS ONE, V10
  31. Ozaydin-Yavuz G, 2019, POSTEP DERM ALERGOL, V36, P76, DOI 10.5114/ada.2019.82915
  32. Patel H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-39
  33. Rodrigues LLS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215001
  34. Schabath MB, 2015, SEX TRANSM INFECT, V91, P61, DOI 10.1136/sextrans-2013-051422
  35. Sudenga SL, 2017, INT J CANCER, V140, P337, DOI 10.1002/ijc.30452
  36. Velazquez-Hernandez Nadia, 2019, J Clin Med Res, V11, P196, DOI 10.14740/jocmr3739
  37. Wendland E. M., 2020, SCI REPORTS, V10, P1, DOI 10.1038/s41598-020-61582-2.
  38. Wendland EM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011758
  39. Zhu CS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023897

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03
Artigos e Materiais de Revistas Científicas - ODS/05